Capstone Investment Advisors
NVAX icon

Capstone Investment Advisors’s Novavax NVAX Stock Holding History

Capstone Investment Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,360
Closed -$32.4K – 1968
2024
Q3 		$42.4K Buy
+3,360
New +$43.4K ﹤0.01% 1818
2024
Q2 		– Sell
-41,194
Closed -$414K – 2345
2024
Q1 		$197K Buy
+41,194
New +$191K ﹤0.01% 2019
2023
Q4 		– Sell
-15,111
Closed -$92.5K – 2303
2023
Q3 		$109K Buy
15,111
+13,427
+797% +$107K ﹤0.01% 1936
2023
Q2 		$12.5K Buy
1,684
+1,638
+3,561% +$12.9K ﹤0.01% 1816
2023
Q1 		$319 Buy
+46
New +$423 ﹤0.01% 1527
2022
Q2 		– Sell
-2,810
Closed -$207K – 2026
2022
Q1 		$207K Buy
+2,810
New +$251K ﹤0.01% 1694
2016
Q4 		– Sell
-9,466
Closed -$393K – 1052
2016
Q3 		$393K Buy
+9,466
New +$1.22M 0.01% 553

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capstone Investment Advisors's NVAX Position: Q4 2024 in Review

Capstone Investment Advisors sold out of Novavax (NVAX) in Q4 2024, closing a stake of 3,360 shares — an estimated $32.4K sold.

Capstone Investment Advisors first reported a position in NVAX in Q3 2016 and held it in 7 quarters. The position peaked at $393K in Q3 2016. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2024.

  • Capstone Investment Advisors reported no remaining Novavax position as of Q4 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 3,360 Novavax shares in Q4 2024, an estimated $32.4K.
  • Capstone Investment Advisors first reported a position in Novavax in Q3 2016 and held it in 7 quarters.
  • Capstone Investment Advisors's Novavax position peaked at $393K in Q3 2016.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2024.

Based on Capstone Investment Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.